摘要Colorectal cancer is often accompanied by multiple organ metastasis.Anaerobic Bifidobacterium Infantis(BI)bacterial can selectively grow in hypoxic colorectal tumor microenvironment(TME),to own the natural advantage of preferentially colorectal tumor targeting.Herein,a self-guidance biological hybrid drug delivery system(BI-ES-FeAlg/DOX)based on BI was constructed to inhibit the proliferation and metastasis of colon cancer.Results demonstrated that BI-ES-FeAlg/DOX could overcome physical barriers to target and accumulate in colon tumor tissues.Then DOX was released to kill tumor cells along with the phase transition(solid to liquid)of FeAlg hydrogel,due to Fe3+was reduced to Fe2+by intracellular GSH.Meanwhile,BI-ES selectively colonized into tumors and expressed endostatin(ES)protein to down-regulate VEGF and bFGF expression,exerting anti-angiogenic effect.Moreover,FeAlg catalyzed H202 in the local tumor to generate cytotoxic OH,further enhancing the antitumor effect.The pharmacodynamic result in AOM/DSS model proved that BI-ES-FeAlg/DOX had the best therapeutic effect,with the final V/V0 of 2.19±0.57,which was significantly lower than the other groups.Meanwhile,on CT-26 tumor-bearing model,it also showed an outstanding anti-tumor effect with inhibition rate of 82.12％±3.08％.In addition,lung metastases decreased significantly in tumor metastasis model after BI-ES-FeAlg/DOX treatment.